Sangamo BioSciences | Stammkapital


Ordinary Share Capital Veränderung
Alnylam Pharmaceuticals ALNY:US $ 1.21M 0M
Amgen AMGN:US $ 31343M 96M
Avrobio Inc AVRO:US $ 4K 0
Bayer BAYN:GR € 2515M 0M
Biogen BIIB:US $ 0.1M 0M
Biomarin Pharmaceutical BMRN:US $ 0.19M 0M
Bluebird Bio BLUE:US $ 0.74M 0.02M
GlaxoSmithKline GSK:LN 134700M 0M
Intercept Pharmaceuticals ICPT:US $ 0.03M 0M
IONIS PHARMACEUT IONS:US $ 0.14M 0M
Karyopharm Therapeutics KPTI:US $ 8K 0
Novartis NOVN:VX SF 890M 11M
Omeros OMER:US $ 627K 0
Regulus Therapeutics RGLS:US $ 0.02M 0.13M
Sangamo Biosciences SGMO:US $ 1.53M 0.07M
Sarepta Therapeutics SRPT:US $ 0.01M 0M
Ultragenyx Pharmaceutical RARE:US $ 0.07M 0M
Vertex Pharmaceuticals VRTX:US $ 2.6M 0M
Ziopharm Oncology ZIOP:US $ 0.22M 0M



Sangamo BioSciences Stammkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Sep 2022.